Naruto Taira
Kurashiki, 7010192, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 133 publications
Peripheral Blood T-Cell Receptor Repertoire and Host Immune Background in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.
Journal: Acta medica Okayama
Published: June 30, 2026
Association of zinc transporter expression with clinicopathological features and prognosis in patients with breast cancer.
Journal: Medical molecular morphology
Published: June 18, 2026
Efficacy of adjuvant chemotherapy for triple-negative early breast cancer with tumor size ≤ 1 cm and node-negative from the National Clinical Database-Breast Cancer Registry in Japan.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 06, 2026
Abemaciclib plus endocrine therapy in chemotherapy-treated patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer.
Journal: Breast cancer (Tokyo, Japan)
Published: February 12, 2026
Minimal important differences of EORTC QLQ-C30 and QLQ-BR23 for metastatic breast cancer patients in a Japanese population: results from the RESQ trial.
Journal: Breast cancer (Tokyo, Japan)
Published: February 12, 2026
Post-mastectomy radiation therapy in Poland syndrome with left breast cancer: A case report.
Journal: Experimental and therapeutic medicine
Published: February 09, 2026
Real-world data for a CDK4/6 inhibitor, palbociclib, as 1st- or 2nd-line therapy in HR+/HER2- metastatic breast cancer: a multicenter prospective cohort study.
Journal: Breast cancer research : BCR
Published: February 02, 2026
Annual report of national clinical database-breast cancer registry in 2023: systemic therapy for small breast cancer.
Journal: Breast cancer (Tokyo, Japan)
Published: January 28, 2026
Prognosis of ER-positive, HER2-negative postmenopausal early breast cancer patients based on response to neoadjuvant endocrine therapy and multigene assay results: findings from the NEOS trial.
Journal: Breast cancer (Tokyo, Japan)
Published: January 27, 2026
Chemotherapy is associated with differential survival outcomes in apocrine carcinoma: A nationwide cohort study from the Japanese National Clinical Database-Breast Cancer Registry.
Journal: Breast (Edinburgh, Scotland)
Published: January 08, 2026
Risk factors and metastatic sites in HER2-positive breast cancer with pathological complete response.
Journal: NPJ breast cancer
Published: January 06, 2026
Health-related quality of life with pertuzumab retreatment: Secondary analysis of the PRECIOUS trial.
Journal: Breast (Edinburgh, Scotland)
Published: November 19, 2025
Last Updated: 09/26/2026